High plasma levels of adipocytokines are associated with platelet activation in patients with coronary artery disease

References

• Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79–83
   PubMed Web of Science ®Google Scholar
• Otsuka F, Sugiyama S, Kojima S, Maruyoshi H, Funahashi T, Matsui K, Sakamoto T, Yoshimura M, Kimura K, Umemura S, Ogawa H. Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease. J Am Coll Cardiol 2006; 48: 1155–1162
   PubMed Web of Science ®Google Scholar
• Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT, Pinsky DJ, Marmur JD. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 2006; 27: 2300–2309
   PubMed Web of Science ®Google Scholar
• Broedl UC, Lebherz C, Lehrke M, Stark R, Greif M, Becker A, von Ziegler F, Tittus J, Reiser M, Becker C, et al. Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques. PLoS ONE 2009; 4: e4733
   Web of Science ®Google Scholar
• Schnabel R, Messow CM, Lubos E, Espinola-Klein C, Rupprecht HJ, Bickel C, Sinning C, Tzikas S, Keller T, Genth-Zotz S, et al. Association of adiponectin with adverse outcome in coronary artery disease patients: Results from the AtheroGene study. Eur Heart J 2008; 29: 649–657
   PubMed Web of Science ®Google Scholar
• Spranger J, Kroke A, Möhlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003; 361: 226–228
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004; 24: 29–33
   PubMed Web of Science ®Google Scholar
• Hara K, Yamauchi T, Imai Y, Manabe I, Nagai R, Kadowaki T. Reduced adiponectin level is associated with severity of coronary artery disease. Int Heart J 2007; 48: 149–153
   PubMed Web of Science ®Google Scholar
• Fantuzzi G. Adiponectin and inflammation: Consensus and controversy. J Allergy Clin Immunol 2008; 121: 326–330
   PubMed Web of Science ®Google Scholar
• Dubey L, Zeng H, Hashmi S, Hongjie W, Tao H. Association of plasma leptin levels and complexity of the culprit lesion in patients with unstable angina. Int J Cardiol 2008; 126: 183–189
   PubMed Web of Science ®Google Scholar
• Taneli F, Yegane S, Ulman C, Tikiz H, Bilge AR, Ari Z, Uyanik BS. Increased serum leptin concentrations in patients with chronic stable angina pectoris and ST-elevated infarction. Angiology. 2006; 57: 267–272
   PubMed Web of Science ®Google Scholar
• Raaz D, Wallaschofski H, Stumpf C, Yilmaz A, Cicha I, Klinghammer L, Daniel WG, Lohmann T, Garlichs CD. Increased prolactin in acute coronary syndromes as putative Co-activator of ADP-stimulated P-selectin expression. Horm Metab Res 2006; 38: 767–772
   PubMed Web of Science ®Google Scholar
• Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595–1599
   PubMed Web of Science ®Google Scholar
• Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, et al. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473–2476
   PubMed Web of Science ®Google Scholar
• Harsch IA, Bergmann T, Koebnick C, Wiedmann R, Ruderich F, Hahn EG, Konturek PC. Adiponectin, resistin and subclinical inflammation–the metabolic burden in Launois Bensaude Syndrome, a rare form of obesity. J Physiol Pharmacol 2007; 58(Suppl 1): 65–76
   PubMedGoogle Scholar
• Bigalke B, Lindemann S, Ehlers R, Seizer P, Daub K, Langer H, Schonberger T, Kremmer E, Siegel-Axel D, May AE, Gawaz M. Expression of platelet collagen receptor glycoprotein VI is associated with acute coronary syndrome. Eur Heart J 2006; 27: 2165–2169
   PubMed Web of Science ®Google Scholar
• Bigalke B, Geisler T, Stellos K, Langer H, Daub K, Kremmer E, Seizer P, May AE, Lindemann S, Gawaz M. Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome. Am Heart J 2008; 156: 193–200
   PubMed Web of Science ®Google Scholar
• Bigalke B, Stellos K, Geisler T, Kremmer E, Seizer P, May AE, Lindemann S, Melms A, Luft A, Gawaz M. Expression of platelet glycoprotein VI is associated transient ischemic attack and stroke. Eur J Neurol 2009, [Epub ahead of print]
   PubMedGoogle Scholar
• Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Jr, Chavey WE, 2nd, Fesmire FM, Hochman JS, Levin TN, et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): Developed in with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007; 116: e148–304
   PubMed Web of Science ®Google Scholar
• Sinha MK, Songer T, Xiao Q, Sloan JH, Wang J, Ji S, Alborn WE, Davis RA, Swarbrick MM, Stanhope KL, et al. Analytical validation and biological evaluation of a high molecular-weight adiponectin ELISA. Clin Chem 2007; 53: 2144–2151
   PubMedGoogle Scholar
• Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: 41–55
   Web of Science ®Google Scholar
• D'Agostino RB, Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statist Med 1998; 17: 2265–2281
   PubMed Web of Science ®Google Scholar
• Rudner LM, Peyton J. Consider Propensity Scores to Compare Treatments. PARE 2006; 11: 1–9
   Google Scholar
• Krzyzanowska K, Aso Y, Mittermayer F, Inukai T, Brix J, Schernthaner G. High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes. Transl Res 2009; 153: 199–203
   PubMedGoogle Scholar
• von Eynatten M, Humpert PM, Bluemm A, Lepper PM, Hamann A, Allolio B, Nawroth PP, Bierhaus A, Dugi KA. High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men. Atherosclerosis. 2008; 199: 123–128
   PubMedGoogle Scholar
• Liang KW, Lee WJ, Lee WL, Ting CT, Sheu WH. Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis. Clin Chim Acta 2009; 405: 114–118
   PubMedGoogle Scholar
• Nakamura Y, Shimada K, Fukuda D, Shimada Y, Ehara S, Hirose M, Kataoka T, Kamimori K, Shimodozono S, Kobayashi Y, Yoshiyama M, Takeuchi K, Yoshikawa J. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 2004; 90: 528–533
   PubMed Web of Science ®Google Scholar
• Ang DS, Welsh P, Watt P, Nelson SM, Struthers AD, Sattar N. Serial changes in adiponectin and BNP in ACS patients: Paradoxical associations with each other and with prognosis. Clin Sci (Lond) 2009; 117: 41–48
   PubMedGoogle Scholar
• Wallander M, Söderberg S, Norhammar A. Leptin: A predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes. Diabet Med 2008; 25: 949–955
   PubMed Web of Science ®Google Scholar
• Piestrzeniewicz K, Luczak K, Komorowski J, Maciejewski M, Goch JH. The relationship between leptin and obesity and cardiovascular risk factors in men with acute myocardial infarction. Cardiol J 2007; 14: 252–259
   PubMedGoogle Scholar
• Koh KK, Quon MJ, Waclawiw MA. Are statins effective for simultaneously treating dyslipidemias and hypertension?. Atherosclerosis 2008; 196: 1–8
   PubMed Web of Science ®Google Scholar
• Azar RR, Sarkis A, Salameh E, Gannagé-Yared MH, Amm-Azar M, Badaoui G, Germanos M, Kassab R. Percutaneous coronary intervention increases leptin and decreases adiponectin levels. Clin Endocrinol 2006; 65: 712–716
   PubMedGoogle Scholar
• Harsch IA, Wallaschofski H, Koebnick C, Pour Schahin S, Hahn EG, Ficker JH, Lohmann T. Adiponectin in patients with obstructive sleep apnea syndrome: Course and physiological relevance. Respiration 2004; 71: 580–586
   PubMedGoogle Scholar
• Kato H, Kashiwagi H, Shiraga M, Tadokoro S, Kamae T, Ujiie H, Honda S, Miyata S, Ijiri Y, Yamamoto J, Maeda N, Funahashi T, Kurata Y, Shimomura I, Tomiyama Y, Kanakura Y. Adiponectin acts as an endogenous antithrombotic factor. Arterioscler Thromb Vasc Biol 2006; 26: 224–230
   PubMed Web of Science ®Google Scholar
• Wallaschofski H, Lohmann T, Hild E, Kobsar A, Siegemund A, Spilcke-Liss E, Hentschel B, Stumpf C, Daniel WG, Garlichs CD, Eigenthaler M. Enhanced platelet activation by prolactin in patients with ischemic stroke. Thromb Haemost 2006; 96: 38–44
   PubMed Web of Science ®Google Scholar
• Raaz D, Wallaschofski H, Stumpf C, Yilmaz A, Cicha I, Klinghammer L, Daniel WG, Lohmann T, Garlichs CD. Increased prolactin in acute coronary syndromes as putative Co-activator of ADP-stimulated P-selectin expression. Horm Metab Res 2006; 38: 767–772
   PubMed Web of Science ®Google Scholar
• Bigalke B, Stellos K, Stakos D, Joos T, Pötz O, Geisler T, Bischofs C, Kremmer E, Krämer BF, Seizer P, May AE, Lindemann S, Gawaz M. Influence of platelet count on the expression of platelet collagen receptor glycoprotein VI (GPVI) in patients with acute coronary syndrome. Thromb Haemost 2009; 101: 911–915
   PubMed Web of Science ®Google Scholar
• Nakata M, Yada T, Soejima N, Maruyama I. Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes 1999; 48: 426–429
   PubMed Web of Science ®Google Scholar
• Dellas C, Schäfer K, Rohm I, Lankeit M, Ellrott T, Faustin V, Riggert J, Hasenfuss G, Konstantinides S. Absence of leptin resistance in platelets from morbidly obese individuals may contribute to the increased thrombosis risk in obesity. Thromb Haemost 2008; 100: 1123–1129
   PubMed Web of Science ®Google Scholar